This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Psimos, Inc., Psirrros Inc.. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2025
Title: Maxim Yurievich Mitrohin: Innovator in Pharmaceutical Technology
Introduction
Maxim Yurievich Mitrohin is a notable inventor based in Moscow, Russia. He has made significant contributions to the field of pharmaceutical technology, particularly in the area of individualized medicine dosing. With a total of 2 patents to his name, Mitrohin's work is paving the way for advancements in medical science.
Latest Patents
Mitrohin's latest patents include a finished pharmaceutical form with individual medicine dosing capability and methods of its production and use. This invention describes a method and system that involves receiving a first quantity of at least one medicine in cartridges of a printing device, dispensing a drop of the medicine onto a porous media, and drying the dispensed drop. The invention aims to enhance the precision of medicine dosing, which is crucial for effective treatment. Another patent focuses on a new type of finished pharmaceutical form that includes a storage container and a carrier for the medicine, along with suggested methods for its production and use.
Career Highlights
Throughout his career, Mitrohin has worked with various companies, including Psirrros Inc. and Psimos, Inc. His experience in these organizations has contributed to his expertise in pharmaceutical technology and innovation.
Collaborations
Mitrohin has collaborated with notable individuals in his field, including Sergey Emilevich Kondakov and Aleksandr Pavlovich Osipov. These collaborations have likely enriched his work and expanded the impact of his inventions.
Conclusion
Maxim Yurievich Mitrohin is a distinguished inventor whose work in pharmaceutical technology is making a significant impact. His innovative patents and collaborations reflect his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile